Innovus Pharmaceuticals Inc. (fka INNV)

[ShawnP123]

Dilution, Dilution, Dilution. That's about it with this company. Every time you looks it's either need for more shares or more share outstanding. Damaj did the exact same thing at Apricus. His tenure as CEO there was short and the stock started to collapse about 4-6 months prior to his leaving.

I'm now thinking about 150 - 160M shares outstanding by April 2. I believe the stock will take a steep dive then. Even if Fluticare does get approved, he will need more money to take it to market.